371 results about "Instructions for use" patented technology

An imaging system for use in medical intervention procedure planning includes a medical scanner system for generating a volume of cardiac image data, a data acquisition system for acquiring the volume of cardiac image data, an image generation system for generating a viewable image from the volume of cardiac image data, a database for storing information from the data acquisition and image generation systems, an operator interface system for managing the medical scanner system, the data acquisition system, the image generation system, and the database, and a post-processing system for analyzing the volume of cardiac image data, displaying the viewable image and being responsive to the operator interface system. The operator interface system includes instructions for using the volume of cardiac image data and the viewable image for bi-ventricular pacing planning, atrial fibrillation procedure planning, or atrial flutter procedure planning.

Systems, kits, and methods for establishing vascular access are described. A system may include a needle, a radially expandable sleeve and a dilator. The methods include creating an initial tissue tract to a target blood vessel with a radially expandable sleeve mounted on a needle. Upon removal of the needle, the dilator is then passed through the radially expandable sleeve to effect radial expansion of the sleeve. Use of the sleeve reduces the risk of injuring tissue surrounding the tissue tract by lessening the axial forces imparted to the tissue. Kits comprise at least the radially expandable sleeve together with instructions for use.

A wireless communications network and method include a home system, a serving system, and authentication failure triggers. The home system includes an authentication center, a network information element, and a prescribed authentication capable mobile station. The authentication center performs an authentication of the prescribed mobile station upon a network access by the mobile station. Authentication includes use of shared secret data particular to the prescribed mobile station. The serving system includes a network access element and a network information element associated therewith. The serving system is capable of performing authentication upon authentication capable mobile stations. Lastly, the authentication failure triggers and shared secret data are shared with the serving system by the authentication center of the home system upon the mobile station's initial system access. The authentication failure triggers include instructions for use by the serving system with respect to authentication failures which may occur during a subsequent serving system access. The authentication triggers direct the serving system to handle authentication failures according to the authentication policies of the home system's authentication center. Therefore, the requirement for the authentication failure report operation is advantageously reduced.

The invention provides an in vivo screening assay and an in vitro screening assay for rapid screening of diabetes. A method of the invention includes determining a first glucose concentration in an ocular fluid of a patient; administering orally a load of carbohydrate to the patient; determining a second glucose concentration in an ocular fluid of the patient at a period of time of less than 50 minutes after orally administering of the load of carbohydrate; comparing the second glucose concentration with the first glucose concentration to determine if the patient is likely to be a diabetic. The method of the invention is performed by using a kit of the invention. The kit comprises: (1) a glucose-sensing ophthalmic device and instructions for using the glucose-sensing ophthalmic device to screen for diabetes; or (2) two or more tear-collecting devices, and a testing agent composition which specifically reacts with glucose to form a detectable signal. The glucose-sensing ophthalmic device comprises a testing agent composition which specifically and reversibly interacts with glucose to form a detectable optical signal which changes in a concentration-dependent manner.

An architecture and system are described that provide a unified file access service within in a managed computing environment composed of diverse networks, computing devices, and storage devices. The service provides mechanisms for remotely accessing the file systems of any managed computer or disk snapshot, independently of the computer's current state (powered on, suspended or powered off), its location within the environment, its hardware type (virtual vs. physical), its operating system type, and its file system formats. The system isolates centralized FPAs from the details of clients, proxies and storage elements by providing a service that decomposes offloaded file system access into two steps. A FPA or a requester acting on behalf of the FPA first expresses the disk set or the computer containing the file systems it wishes to access, along with requirements and preferences about the access method. The service figures out an efficient data path satisfying the FPA's needs, and then automatically configures a set of storage and computing resources to provide the data path. The service then replies with information about the resources and instructions for using them. The FPA then accesses the requested file systems using the returned information.

Printed instructions (4000) can be included with the tray (100) in a medical procedure kit. The printed instructions (4000) can include instructional material (4202), such as pictorial, step-by-step instructions for using the medical procedure kit. The printed instructions (4000) can be configured as a booklet. The printed instructions (4000) can be adhesively attached to outer packaging (4201), and can include a peelable label (4402) that is separable from the printed instructions (4000) and is configured for attachment to medical records. Colorization of the various components can assist in ensuring safe usage of the medical procedure kit.

A multilayer Paper Analytical Device (PAD) is provided for detection of at least two chemical components indicative of a low quality pharmaceutical or dietary supplement product. A method for detection of at least two chemical components indicative of a low quality pharmaceutical or dietary supplement product is also provided that employs a multilayer PAD. A kit is provided for detection of at least two chemical components indicative of a low quality pharmaceutical or dietary supplement product that includes a multilayer PAD and instructions for using the kit.

An interface unit is disclosed for facilitating the optimization of a watering system. The interface unit includes a first interface configured to receive optimization data over a network. A second interface is also included, the second interface being configured for electronic communications with a watering system controller that controls operation of a watering system according to watering instructions stored in the watering system controller. The interface unit also includes a processor, the processor being in electronic communication with the first interface and the second interface. Memory is also included. The memory is in electronic communication with the processor, and is programmed with instructions for using the optimization data to modify the watering instructions.

The present application provides methods of purifying Aβ binding proteins having a Fc region, for example, anti-Aβ antibodies or antibody fusions, by adsorbing the Aβ binding protein to a Fc binding agent, such as, for example, Protein A or Protein G, followed by a wash with a divalent cation salt buffer to remove impurities and subsequent recovery of the adsorbed Aβ binding protein. The present application also features methods of eluting the purified Aβ binding protein as well as the incorporation of the methods within a purification train. Kits comprising components for carrying out the methods and instructions for use are also provided.

A motion control system and method that includes a central controller configured to generate first and second demand control signals to be used to define actuation motion of respective first and second actuators. The central controller is in communication with first and second nodes by way of a data network, each node including at least a respective actuator configured to implement at an actuator time a motion or force-related effort based upon the respective demand control signal. Each node also includes a memory configured to store at least one respective propagation delay parameter related to a signal propagation delay between the central controller and the node. A timing mechanism establishes timing at each node based on the respective propagation delay parameter so that the actuator time at the nodes occurs simultaneously. Strictly cyclic and / or full-duplex high-speed communication can be supported. The network can be wired in a ring or as a tree and with twisted pair cabling or fiber. The central controller issues demand signals to the nodes that are actuator, servo motor drive, and / or I / O devices. The central controller can also provide a timing message that is used by the nodes, in conjunction with local delay correction circuitry, so that the simultaneous acquisition of data and the simultaneous implementation of controlled action occur.

Compounds and compositions for the transient expression of exogenous telomerase activity in a cell are provided. The compounds and compositions, which relate to a ribonucleic acid coding for a telomerase reverse transcriptase, are useful in the extension of telomeres in cells needing such treatment. Such cells include, for example, cells that contain shortened telomeres and cells from subjects that may benefit from telomere extension, for example subjects that suffer from, or are at risk of suffering from, age-related or other illnesses. Also provided are methods of extending telomeres through the administration of the provided compounds and compositions to animal cells, either in vitro or in vivo, and kits including the compounds or compositions and instructions for use.